Market Tracker

06/23 5:16pm ET

Albany Molecular Research Inc (NASDAQ:AMRI)

21.71
Delayed Data
As of 3:59pm ET
 +0.03 / +0.14%
Today’s Change
12.51
Today|||52-Week Range
22.17
+15.72%
Year-to-Date
No recent news for Albany Molecular Research Inc.

Today’s Trading

Previous close21.68
Today’s open21.68
Day’s range21.61 - 21.73
Volume1,293,107
Average volume (3 months)1,132,939
Market cap$930.8M
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-2,514.29%
Earnings growth (this year)+18.95%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+41.36%
P/E ratioNM
Price/Sales1.26
Price/Book3.11

Competitors

 Today’s
change
Today’s
% change
AMRNAmarin Corporation P...+0.05+1.51%
MEDPMedpace Holdings Inc+0.46+1.60%
RGNXRegenxbio Inc+0.80+3.79%
BSTCBiospecifics Technol...-0.73-1.47%
Data as of 4:14pm ET, 06/23/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)$0.28
Annual revenue (last year)$568.8M
Annual profit (last year)-$70.2M
Net profit margin-12.34%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
William S. Marth
Chief Operating Officer
George Svokos
Corporate headquarters
Albany, New York

Forecasts